Publications
- Changes in MYCN expression in human neuroblastoma cell lines following cisplatin treatment may not be related to MYCN copy numbers2013 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Premature aging in childhood cancer survivors (Review)2023 | Second Faculty of Medicine
- KDM5B expression in cisplatin resistant neuroblastoma cell lines2022 | Second Faculty of Medicine
- Semen analysis and treatment risk factors in long-term survivors of childhood cancer2021 | Second Faculty of Medicine, Central Library of Charles University
- Nanomedicine of tyrosine kinase inhibitors2021 | Faculty of Science, Second Faculty of Medicine
- Apoferritin/vandetanib association is long-term stable but does not improve pharmacological properties of vandetanib2021 | Faculty of Science, Second Faculty of Medicine
- Is There a Higher Incidence of Sporadic Renal Angiomyolipoma in Childhood Cancer Survivors?2021 | Second Faculty of Medicine, Faculty of Medicine in Pilsen
- Metallothionein-3 promotes cisplatin chemoresistance remodelling in neuroblastoma2021 | Second Faculty of Medicine
- Miat is an upstream regulator of nmyc and the disruption of the miat/nmyc axis induces cell death in nmyc amplified neuroblastoma cell lines2021 | Second Faculty of Medicine
- Possible mechanisms of subsequent neoplasia development in childhood cancer survivors: A review2021 | Second Faculty of Medicine
Loading network view...